Literature DB >> 23850296

Comparison of TNM-based stage grouping versus UICC/AJCC stage grouping (7th edition) in malignant parotid gland tumors.

Matthias Kreppel1, Martin Scheer2, Moritz Meyer3, Markus Stenner3, Inga Wedemeyer4, Uta Drebber4, Robert Semrau5, Margarete Odenthal4, Joachim E Zöller2, Orlando Guntinas-Lichius6, Reinhard Büttner4, Dirk Beutner3.   

Abstract

BACKGROUND: Although the UICC/AJCC's TNM staging of the 7th edition was improved in 2002, there are still shortcomings concerning the prognostic quality. Alternative TNM-based stage-groupings such as the T and N Integer Score (TANIS) where shown to have a better prognostic quality for various kinds of head and neck tumors in the past. The aim of the study was to compare the prognostic value of the 7th edition of the UICC/AJCC TNM-classification for carcinoma of the parotid gland with different TNM-based stage groupings.
METHODS: The retrospective analysis included 180 patients with carcinoma of the parotid gland diagnosed between 1986 and 2007. The stage grouping system of the 7th edition of the UICC/AJCC and TNM-based stage-groupings (TANIS-3, TANIS-8, Snyderman, Berg and Hart) were tested for their prognostic significance. Overall survival (OS) was plotted by Kaplan-Meier analysis. Prognostic factors were identified through univariate and multivariate analysis.
RESULTS: In univariate analysis all stage-groupings had a highly significant impact on overall survival (p<0.05), however in multivariate analysis, only the TANIS-8 scheme (p=0.008) and Snyderman scheme (p=0.047) predicted OS, while the UICC/AJCC-classification did not predict OS significantly (p=0.381).
CONCLUSION: In comparison to other TNM-based stage groupings the UICC/AJCC-classification did not provide significant prediction of OS, while alternative stage-groupings such as the TANIS-8 had a higher prognostic value.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Multivariate analysis; Parotid gland cancer; Prognosis; Stage grouping; TANIS

Mesh:

Year:  2013        PMID: 23850296     DOI: 10.1016/j.oraloncology.2013.06.009

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  5 in total

1.  Prognostic value of comorbidities in patients with carcinoma of the major salivary glands.

Authors:  Christoph Becker; Kilian Konrad Kenjiro Dahlem; Jens Pfeiffer
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-11-25       Impact factor: 2.503

2.  Incidence, treatment, and outcome of parotid carcinoma, 1996-2011: a population-based study in Thuringia, Germany.

Authors:  Orlando Guntinas-Lichius; Thomas G Wendt; Jens Buentzel; Dirk Esser; Daniel Böger; Andreas H Mueller; Jörn-Uwe Piesold; Stefan Schultze-Mosgau; Peter Schlattmann; Harald Schmalenberg
Journal:  J Cancer Res Clin Oncol       Date:  2015-03-24       Impact factor: 4.553

3.  Health-related quality of life in patients with major salivary gland carcinoma.

Authors:  Christoph Becker; Jens Pfeiffer; Kitty Lange; Kilian Konrad Kenjiro Dahlem
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-02-24       Impact factor: 2.503

4.  Multicenter experiences in temporal bone cancer surgery based on 89 cases.

Authors:  Małgorzata Wierzbicka; Kazimierz Niemczyk; Antoni Bruzgielewicz; Marcin Durko; Janusz Klatka; Tomasz Kopeć; Ewa Osuch-Wójcikiewicz; Wioletta Pietruszewska; Marcin Szymański; Witold Szyfter
Journal:  PLoS One       Date:  2017-02-22       Impact factor: 3.240

5.  A Parsimonious Prognostic Model and Heat Map for Predicting Survival Following Adjuvant Radiotherapy in Parotid Gland Carcinoma With Lymph Node Metastasis.

Authors:  Wen-Mei Jiang; Lei-Lei Wu; Huan-Ye Wei; Qi-Long Ma; Quan Zhang
Journal:  Technol Cancer Res Treat       Date:  2021 Jan-Dec
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.